Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Beximco Pharmaceuticals Ltd - Bangladesh-based pharmaceutical company - Changes name of the recently acquired subsidiary, Sanofi Bangladesh Ltd, to Synovia Pharma PLC, effective from 1 April. Beximco acquired the business from French biopharmaceutical company Sanofi SA.
‘Synovia Pharma will continue to manufacture, market and import Sanofi products, ensuring continued supply for patients in Bangladesh across therapeutic areas such as cardiology, diabetes, oncology, dermatology and CNS,’ Beximco explains.
‘These treatments, as well as opportunities to introduce Sanofi's future global brands, will drive future growth of Beximco Pharma by expanding its addressable market and reinforcing the company's commitment to ensure access to breakthrough therapies and affordable medicines.’
Current stock price: 99.00 pence
12-month change: up 13%
Copyright 2022 Alliance News Limited. All Rights Reserved.